An Internet of Things–Based Audio and Radio Connected System Supporting Older Adults With Physical and Cognitive Health Challenges: Qualitative Stakeholder-Informed Design Study

<strong>Background:</strong> Older adults managing chronic illnesses, such as cancer and Alzheimer disease and related dementias (ADRD), often experience significant physical or cognitive impairments that hinder daily activities and increase caregiver burden. Smart Internet of Things (IoT) technologies offer promising solutions by enabling passive monitoring, timely reminders, and personalized support at home. However, these technologies must be carefully tailored to accommodate users’ individualized needs and preferences. <strong>Objective:</strong> This formative qualitative study aimed to explore stakeholder perspectives, including patients, caregivers, health care providers, and technical experts, on the use of smart home–based IoT systems to support chronic illness management. The goal was to inform the early development of the audio and radio connected (AURA) system, an IoT prototype integrating Wi-Fi sensing, wearable trackers, and voice-assistive features. <strong>Methods:</strong> Semistructured interviews were conducted with 6 patients who underwent postostomy creation for colorectal or bladder cancer treatment and 5 patients with ADRD and their caregivers. Input from additional stakeholders, including 2 health care providers, 2 community health workers, and 2 computer scientists, was also included in the report. Stakeholders reviewed a demonstration video depicting the conceptual features of the AURA system. Interviews explored stakeholders’ needs and preferences for using such systems. Thematic analysis was guided by the extended Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) framework, with 5 adapted constructs: performance expectancy, effort expectancy, social influence, facilitating conditions, and hedonic motivation and habit. <strong>Results:</strong> Stakeholders identified distinct yet complementary needs across populations. Patients with cancer emphasized physical health monitoring, integration with health care systems, and customization; ADRD stakeholders prioritized routine support, emotional engagement, and simplicity; caregivers and clinicians emerged as key influencers of adoption. Barriers included privacy concerns, technology literacy, and fatigue, while facilitators included perceived caregiving support, streamlined interfaces, and electronic health record integration. Patients with cancer focused on motivational cues for physical activity, while emotional engagement and habit were more prominent for ADRD users. <strong>Conclusions:</strong> Stakeholder insights underscore the importance of designing adaptable, user-centered IoT systems that reflect the varied capabilities and care needs of older adults with chronic illnesses. These findings informed the design of the AURA prototype and highlighted theoretical considerations for technology acceptance in health care. Future work will test AURA in real-world settings to evaluate usability, acceptability, and clinical relevance. <strong>Trial Registration:</strong>

Autonomic-vascular dysregulation in CKD-associated hypertension: a narrative review with evidence hierarchy

Hypertension and chronic kidney disease frequently coexist and mutually accelerate cardiovascular and renal injury. This narrative review prioritizes direct human autonomic phenotyping (Level 1: microneurography, HRV/BRS), human vascular correlates (Level 2: PWV, FMD), and complementary preclinical evidence (Level 3) to elucidate autonomic-vascular mechanisms. Autonomic imbalance, characterized by sympathetic overactivity and reduced parasympathetic restraint, represents a key interface between neural control and vascular pathology in this setting. This narrative review synthesizes experimental and clinical evidence on how the autonomic nervous system shapes vascular function in hypertension and CKD. We outline physiological autonomic control of vascular tone (baroreflex pathways, central networks, brain–kidney communication), characteristic autonomic alterations in hypertension (elevated MSNA, impaired HRV/BRS), and their vascular consequences (endothelial dysfunction, arterial stiffness). We emphasize CKD-specific autonomic drivers (renal afferents, uremic toxins, inflammation) and their translation to exaggerated vascular injury and adverse BP phenotypes. Finally, we discuss pharmacological/device-based strategies targeting autonomic–vascular pathways, highlighting opportunities for neuromodulation, biomarker-guided risk stratification, and individualized treatment. By integrating multidisciplinary evidence, this review frames CKD hypertension as amplified autonomic–vascular injury and positions the autonomic nervous system as a promising therapeutic target.

DeviceTalks Minnesota 2026 show preview: Speakers, exhibitors and more

It’s almost time for our May 4 DeviceTalks Minnesota show at the University of Minnesota’s McNamara Alumni Center in Minneapolis. We’ve got a great lineup of keynotes — Abbott’s Lisa Earnhardt, Solventum’s Heather Knight, Mike Blue at HistoSonics and Medical 21’s Manny Villafaña — plus more interviews and panels of experts from medical device OEMs…

The post DeviceTalks Minnesota 2026 show preview: Speakers, exhibitors and more appeared first on Medical Design and Outsourcing.

Baxter discloses executive pay under new CEO and golden parachute for the last CEO

Baxter International disclosed how much it paid its new CEO last year in a recent filing with the U.S. Securities and Exchange Commission. The medical device manufacturer also disclosed pay packages for other current and former executives — including a severance payment for its former CEO — and reported higher pay for its median employee. Baxter’s…

The post Baxter discloses executive pay under new CEO and golden parachute for the last CEO appeared first on Medical Design and Outsourcing.

Benefit of the N-of-1 Approach Versus Aggregate Analysis in Tracking Individual Trajectories During Pregnancy: Comparison of Longitudinal Wearable Observational Studies

Background: Personal digital health technologies (DHTs) enable real-time monitoring of physiological metrics and behavioral data, including heart rate variability (HRV), supporting analysis of pregnancy-related conditions and personalized care throughout the perinatal period. While recent studies demonstrate the utility of personal DHTs in tracking pregnancy-related symptoms, they often rely on aggregate statistical methods that overlook individual variability. Objective: This study aims to compare aggregate and individual-level analyses of DHT data for pregnancy-related conditions, using the comprehensive BUMP (Better Understanding the Metamorphosis of Pregnancy) dataset to highlight the importance of individual variability and data heterogeneity. Methods: We analyzed wearable and self-reported data from 256 participants enrolled in the BUMP study (January 2021 to May 2022), including HRV, sleep, and fatigue measured via Oura Rings and smartphone surveys. Individual-level (N-of-1) trajectories were evaluated and compared with aggregate results to uncover personal and collective trends. A statistical method was developed to assess the influence of adverse events and severe symptoms, while case studies explored confounding and modifying factors underlying heterogeneity. Comprehensive statistical analysis included the coefficient of determination, Kolmogorov-Smirnov tests, likelihood ratio tests, and Welch tests, with interindividual variability flagged based on high-variability thresholds. Results: Substantial interindividual variability was observed across all features. Only 4.76% (12/256) of participants exhibited an HRV inflection at the aggregate week-33 inflection point, with a coefficient of variation of 14.24%. The median value of the gestational week in individual fatigue troughs was 23 (IQR 8; range 8-38) weeks, differing from aggregate estimates. Distributional comparisons showed no statistically significant differences in individual-level model fit (²) by pregnancy complications or age ( values ranging from .06 to .99 across all model fit comparisons). Case studies further highlighted both intraindividual and interindividual differences, emphasizing the importance of considering external factors, such as adverse events and severe symptoms. Conclusions: Our findings show that aggregate wearable data often fail to generalize across populations, oversimplifying pregnancy-related physiological and subjective changes. This simplification can obscure individual trajectories, leading to generalized insights that may not reflect many pregnant women’s experiences. Our results highlight the impact of heterogeneity on pregnancy outcomes, emphasizing the need to move beyond one-size-fits-all models and leverage DHT for personalized care.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/56f195607607607bbdd89930537aae1a" />

Why Microbot Medical developed a fully disposable surgical robot

Microbot Medical is creating a “whole new category in robotics” with its fully disposable Liberty endovascular navigation surgical robot, co-founder and CEO Harel Gadot says. The medical device developer designed Liberty as a single-use system to overcome adoption barriers in robot-assisted surgery. The main barrier in endovascular surgical robotics is extended setup time, Gadot said, followed…

The post Why Microbot Medical developed a fully disposable surgical robot appeared first on Medical Design and Outsourcing.

TIS for NSSI in Adolescent Depression

Conditions: Temporal Interference Stimulation; Non Suicidal Self Injury; Major Depressive Disorder

Interventions: Device: Active Temporal Interference Stimulation (TIS); Device: Sham Temporal Interference Stimulation (TIS)

Sponsors: The Second Hospital of Anhui Medical University

Recruiting